This Update in Oncology focuses on new treatments for 4 common tumors in patients: prostate cancer, non-small-cell lung cancer, breast cancer, and colorectal cancer. The hot topics in 2004 were docetaxel for prostate cancer and pemetrexed and epidermal growth factor receptor mutations for non-small-cell lung cancer. The major advance for breast cancer was the use of aromatase inhibitors for adjuvant treatment. For colorectal cancer, the major development was the outcome of the trials studying bevacizumab and cetuximab.
|Original language||English (US)|
|Number of pages||6|
|Journal||Annals of internal medicine|
|State||Published - Oct 18 2005|
ASJC Scopus subject areas
- Internal Medicine